UBS Group’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-45,000
Closed -$641K – 7979
2019
Q4
$641K Buy
+45,000
New +$923K ﹤0.01% 4613

Other funds holding BXC

UBS Group's BXC Position: Q3 2026 in Review

UBS Group reduced its BlueLinx (BXC) stake by 66% in Q3 2026, selling an estimated $1.61M and leaving 11,760 shares worth $836K. The position accounts for ﹤0.01% of the portfolio, ranked #5797.

UBS Group first reported a position in BXC in Q4 2014 and has held it in 42 quarters since. The position peaked at $5.16M in Q4 2024. 108 funds tracked by Wall St. Rank hold BXC as of Q3 2026.

  • UBS Group held 11,760 shares of BlueLinx worth $836K as of Q3 2026.
  • UBS Group sold 22,451 BlueLinx shares in Q3 2026, an estimated $1.61M.
  • BlueLinx made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #5797 holding.
  • UBS Group first reported a position in BlueLinx in Q4 2014 and has held it in 42 quarters since.
  • UBS Group's BlueLinx position peaked at $5.16M in Q4 2024.
  • 108 funds tracked by Wall St. Rank held BlueLinx as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.